A University of California at Los Angeles (UCLA) study headed by Antoni Ribas, M.D., Ph.D., is a first - in - human phase I clinical trial combining adoptive cell transfer of a T cell receptor engineered to recognize NY - ESO - 1 along with Yervoy ® (ipilimumab, anti-CTLA-4). (cancerresearch.org)
One approach would be to identify immune cells in a tumour, grow them in a lab, and then infuse them back into the patient — a technique called adoptive cell transfer. (scientificamerican.com)
Several trials of adoptive cell transfer techniques are currently under way for patients with pancreatic cancer, including: (cancerresearch.org)